Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about schizophrenia
Recent news which mentions schizophrenia
Taye Diggs: My sister's schizophrenia diagnosis changed our family—and how I handle my own anxiety: I 'follow her lead'
May 28, 2025
Tags
Make It / Life
Mental health
Wellness
From
CNBC.com News
Thanksgiving Small Bits & Pieces
December 02, 2024
Tags
Eisai (ESAIY ESALF 4523/T)
coronavirus
schizophrenia
From
Stock Gumshoe
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
November 11, 2024
Tickers
ABBV
BMY
NEWS
Tags
Large Cap
Biotech
BMY
From
Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
Tickers
BMY
NEWS
RVPH
Tags
RVPH
News
Health Care
From
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
August 30, 2024
Tickers
BMY
EIX
LUCY
O
Tags
Hurricanes
TRV
utility stocks
From
Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
MDMA/assisted therapy
Benzinga
Markets
From
Benzinga
Psychedelics And Schizophrenia: What's The Link?
February 19, 2023
Tags
Market News
contributors
Cannabis
From
Benzinga
Tips on Managing Your Schizophrenia
August 22, 2022
Tickers
ALKS
Tags
Health & Healthcare
Education
NASDAQ:ALKS
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
June 08, 2022
Tickers
CBD
CURLF
Tags
Market News
Regulations
Schizophrenia
From
Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
April 06, 2022
Tickers
ADXN
Tags
Benzinga
General
Biotech
From
Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
February 24, 2022
Tickers
KRTX
Tags
General
Phase 3 Trial
Biotech
From
Benzinga
Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use
February 08, 2022
Tags
Benzinga
Cannabis
contributors
From
Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
February 08, 2022
Tickers
ALKS
Tags
General
Phase 3 Trial
Biotech
From
Benzinga
Alkermes Highlights Signs and Symptoms of Schizophrenia
January 31, 2022
Tags
Alkermes
National Institute of Mental Health
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
January 10, 2022
Tickers
RVPH
Tags
Briefs
Market News
Long Ideas
From
Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
December 01, 2021
Tickers
BTAI
Tags
Small Cap
Benzinga
Movers
From
Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
Tags
News
Health Care
Contracts
From
Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
November 01, 2021
Tickers
ATAI
Tags
Phase 2 Trial
News
Health Care
From
Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
Tags
TEVA
Market News
Briefs
From
Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
Tags
News
Health Care
Schizophrenia
From
Benzinga
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
September 13, 2021
Tickers
ALKS
Tags
Schizophrenia
Alkermes
opioid use disorder (OUD)
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
September 01, 2021
Tickers
JNJ
Tags
Market News
Briefs
JNJ
From
Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
September 01, 2021
Tickers
TEVA
Tags
TEVA
Market News
Briefs
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.